Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study

被引：31
|
作者：
Reville, Patrick K. [1 ]
Kantarjian, Hagop M. [2 ]
Ravandi, Farhad [2 ]
Jabbour, Elias [2 ]
DiNardo, Courtney D. [2 ]
Daver, Naval [2 ]
Pemmaraju, Naveen [2 ]
Ohanian, Maro [2 ]
Alvarado, Yesid [2 ]
Xiao, Lianchun [3 ]
Alatrash, Gheath [4 ]
Loghavi, Sanam [5 ]
Rausch, Caitlin R. [6 ]
Borthakur, Gautam [2 ]
Konopleva, Marina [2 ]
Cortes, Jorge [7 ]
Kadia, Tapan M. [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, 1400 Holcombe Blvd, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1400 Holcombe Blvd, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, 1400 Holcombe Blvd, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, 1400 Holcombe Blvd, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, 1400 Holcombe Blvd, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Div Pharm, 1400 Holcombe Blvd, Houston, TX 77030 USA
[7] Augusta Univ, Georgia Canc Ctr, 1411 Laney Walker Blvd, Augusta, GA USA
来源：
BLOOD CANCER JOURNAL | 2021年 / 11卷 / 03期
关键词：
TRANSPLANTATION;
D O I：
10.1038/s41408-021-00453-z
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study
    Patrick K. Reville
    Hagop M. Kantarjian
    Farhad Ravandi
    Elias Jabbour
    Courtney D. DiNardo
    Naval Daver
    Naveen Pemmaraju
    Maro Ohanian
    Yesid Alvarado
    Lianchun Xiao
    Gheath Alatrash
    Sanam Loghavi
    Caitlin R. Rausch
    Gautam Borthakur
    Marina Konopleva
    Jorge Cortes
    Tapan M. Kadia
    Blood Cancer Journal, 11
  • [2] Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia
    O'Brien, Maureen M.
    Alonzo, Todd A.
    Cooper, Todd M.
    Levine, John E.
    Brown, Patrick A.
    Slone, Tamra
    August, Keith J.
    Benettaib, Bouchra
    Biserna, Noha
    Poon, Jennifer
    Patturajan, Meera
    Chen, Nianhang
    Simcock, Mathew
    Zimmerman, Linda
    Kolb, E. Anders
    PEDIATRIC BLOOD & CANCER, 2021, 68 (07)
  • [3] Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphoma
    Schwartzberg, Lee
    Hermann, Robert
    Flinn, Ian
    Flora, Douglas
    Hsi, Eric D.
    Hamid, Oday
    Shi, Peipei
    Lin, Boris K.
    Myrand, Scott P.
    Nguyen, Tuan S.
    Dreyling, Martin
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (01) : 91 - 97
  • [4] Results of a Phase 2, Open-Label Study of Idarubicin, Cytarabine, and Nivolumab in Patients With Newly Diagnosed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (02) : 9 - 11
  • [5] High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study
    Jun Li
    Qi Han
    Yanqing Huang
    Yanhui Wei
    Jie Zi
    Lidong Zhao
    Zhimei Cai
    Xuzhang Lu
    Rong Xiao
    Yanming Zhang
    Xiaotian Yang
    Hao Xu
    Naitong Sun
    Wanchuan Zhuang
    Zhengdong Wu
    Yuan Xia
    Yanli Xu
    Bin He
    Wei Zhu
    Fengling Min
    Yongchun Chen
    Banghe Ding
    Peimin Shi
    Jing Xie
    Hua Tang
    Zefa Liu
    Bingzong Li
    Yu Sun
    Hongxia Qiu
    Limin Duan
    Elanora Dovat
    Chunhua Song
    Laszlo SzeKely
    Sinisa Dovat
    Zheng Ge
    Blood Cancer Journal, 12
  • [6] High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study
    Li, Jun
    Han, Qi
    Huang, Yanqing
    Wei, Yanhui
    Zi, Jie
    Zhao, Lidong
    Cai, Zhimei
    Lu, Xuzhang
    Xiao, Rong
    Zhang, Yanming
    Yang, Xiaotian
    Xu, Hao
    Sun, Naitong
    Zhuang, Wanchuan
    Wu, Zhengdong
    Xia, Yuan
    Xu, Yanli
    He, Bin
    Zhu, Wei
    Min, Fengling
    Chen, Yongchun
    Ding, Banghe
    Shi, Peimin
    Xie, Jing
    Tang, Hua
    Liu, Zefa
    Li, Bingzong
    Sun, Yu
    Qiu, Hongxia
    Duan, Limin
    Dovat, Elanora
    Song, Chunhua
    SzeKely, Laszlo
    Dovat, Sinisa
    Ge, Zheng
    BLOOD CANCER JOURNAL, 2022, 12 (10)
  • [7] An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma
    Agulnik, Mark
    Schulte, Brian
    Robinson, Steven
    Hirbe, Angela C.
    Kozak, Kevin
    Chawla, Sant P.
    Attia, Steven
    Rademaker, Alfred
    Zhang, Hui
    Abbinanti, Susan
    Cehic, Rasima
    Monga, Varun
    Milhem, Mohammed
    Okuno, Scott
    Van Tine, Brian A.
    EUROPEAN JOURNAL OF CANCER, 2021, 154 : 201 - 208
  • [8] NIVOLUMAB MAINTENANCE THERAPY FOR PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA IN REMISSION
    Kadia, T.
    Kantarjian, H.
    Jabbour, E.
    Ravandi, F.
    Daver, N.
    Cardenas, P.
    Brandt, M.
    Konopleva, M.
    Cortes, J.
    HAEMATOLOGICA, 2017, 102 : 54 - 54
  • [9] Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study
    Namikawa, Kenjiro
    Kiyohara, Yoshio
    Takenouchi, Tatsuya
    Uhara, Hisashi
    Uchi, Hiroshi
    Yoshikawa, Shusuke
    Takatsuka, Sumiko
    Koga, Hiroshi
    Wada, Naoko
    Minami, Hironobu
    Hatsumichi, Masahiro
    Asada, Suguru
    Namba, Yoshinobu
    Yamazaki, Naoya
    EUROPEAN JOURNAL OF CANCER, 2018, 105 : 114 - 126
  • [10] Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm study
    Harari, Sergio
    Elia, Davide
    Caminati, Antonella
    Geginat, Jens
    Luisi, Francesca
    Pelosi, Giuseppe
    Specchia, Claudia
    Torre, Olga
    Trevisan, Roberta
    Vasco, Chiara
    Zompatori, Maurizio
    Cassandro, Roberto
    LANCET RESPIRATORY MEDICINE, 2024, 12 (12): : 967 - 974
12345